GRP and prostate carcinoma: Previous reports have shown that GRP receptors can activate insulin-like growth factor-1 receptors (IGF-IR) leading to Akt activation in prostate cancer cells (Sumitomo et al, 2001), a mechanism which may underlie bombesin-mediated cell survival.